Skip to main content

Evaluation of the Sebia CAPILLARYS 2 flex piercing for the measurement of HbA(1c) on venous and capillary blood samples.

Heylen O, Van Neyghem S, Exterbille S, Wehlou C, Gorus F, Weets I

Publication: Am J Clin Pathol (2014) • Vol 141 • Page 867-77PMID: 24838332View on PubMed

Purpose

The purpose of this paper was to determine the effects of using capillary versus venous blood, storage, biomarker levels and analyzer type on the measurement of hemoglobin A1c (HbA1c) levels.

Conclusion

There was good agreement between capillary and venous blood HbA1c levels using the Sebia. HbA1c levels in venous blood, as measured on the Sebia analyzer, were stable for at least 8 days at 2-8°C or room temperature, but HbA1c levels increase after storage at 30°C in specimens with elevated or highly elevated initial HbA1c levels. Generally HbA1c levels measured with the Tosoh G7 and the Sebia analyzer agreed. Bias due to labile A1c, 280 umol/L bilirubin, 26 mmol/L triglycerides, and 33-166 g/L hemoglobin was <1 mmol/mol on both the Tosoh G8 and the Sebia analyzer, but the bias due to 1 mmol/mol carbamylated hemoglobin was down to -5mmol/L on the Tosoh G8 and <1 mmol/mol on the Sebia analyzer. While the Sebia was able to separate each of the hemoglobin variants, on the Tosoh G8, hemoglobin D was eluted just after hemoglobin A, and hemoglobin E eluted with hemoglobin A.

Studies (2)

Purpose

The purpose of this study was to determine the effects of analyzer type on the measurement of HbA1c in blood specimens. Capillary blood was collected by fingerprick into EDTA End-to-End capillaries, and venous blood was collected into S-Monovette potassium EDTA tubes. At least 2-3 specimens were used for each analysis, but it was not specified which analysis used capillary versus venous blood.

Summary of Findings

The HbA1c levels in blanks were 2.62 mmol/mol when measured by the Sebia analyzer but increased by only 0.93 mmol/mol for every 1 mmol/mol increase with the Tosoh G7, such that at high levels, HbA1c levels were higher when measured by the Tosoh G7. Bias due to labile A1p, 280 umol/L bilirubin, 26 mmol/L triglycerides, and 33-166 g/L hemoglobin was <1 mmol/mol on both the Tosoh G8 and the Sebia analyzer, but the bias due to 1 mmol/mol carbamylated hemoglobin was down to -5mmol/L on the Tosoh G8 and <1 mmol/mol on the Sebia analyzer. While the Sebia was able to separate each of the hemoglobin variants, on the Tosoh G8, hemoglobin D was eluted just after hemoglobin A and hemoglobin E eluted with hemoglobin A.

  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Diabetes Type 2
    Diabetes Type 1
  • Platforms

    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBiomarker level
    16.6-166 g/L hemoglobin
    26 mmol/L triglycerides
    280 µmol/L bilirubin
    Carbamylated hemoglobin
    Clinical chemistry/auto analyzer SpecificTechnology platform
    Sebia
    Tosoh G7
    Tosoh G8